Hutchison Baiyunshan To Hand Out Medicine Coupons
This article was originally published in PharmAsia News
Executive Summary
Amid the financial crisis, billionaire Li Ka-shing's Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine will issue 6 million medicine coupons worth RMB 30 million nationwide to alleviate the burden of drug expenses for people in China. Consumers can get coupons with a face value of RMB 10-20 to purchase designated Hutchison Baiyunshan-made drugs. This is the first coupon distribution program targeting branded-drug consumption in the country. The exercise will allow the company to promote its products, capture funds, as well as benefit users. Analysts note that it has been Li's style to give profits back to consumers during past economic downturns. (Click here for more - Chinese Language)
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.